Emil Abderhalden

Abderhalden, Emil (1877-1950), professor of physiology (1908-1910) at Berlin, of biochemistry (1911-1945) at Halle/S. (Germany), and of physiological chemistry (1946/47) at Zurich (Switzerland). From 1931-1950 Prof Abderhalden was Presi-... 

Abderhalden, Emil, 1877-1950 (p. 34, Plate 8) born in Oberuzwil, Switzerland, studied medicine in Basel where he graduated as M.D. in 1902. In the same year he moved to Berhn to join Emil Fischer, where he combined chemistry with enzymology (p. 35). In 1908, he was appointed Professor of Physiological Chemistry at the School of Veterinary Medicine in Berhn. In 1911 he became Professor and Head of the Institute of Physiology of the University of Halle/Saale where he worked on the physiology and biochemistry of peptides, proteins and enzymes. Abderhalden was President of the Deutsche Akademie der Naturforscher Leopoldina from 1931 until 1945, the year in which he and his family were moved to West Germany by American troops. He died in 1950 in Zurich, Switzerland. 

Institut fiir Ernahrungsivissenschaften Emil-Abderhalden-StraEe 26 06108 Halle (Saale)... 

H. Hanson, Emil Abderhalden (1877-1950), Nova Acta Leopoldina, 36 257-317 (1970)... 

Frewer, A., Medizin und Moral in Weimarer Republik und Nationalsozialismus. Die Zeitschrift Ethik unter Emil Abderhalden (Frankfurt am Main, New York, Campus Verlag, 2000). 

London found only traces of amino acids in gastric contents during digestion of protein, and he enlisted the cooperation of Emil Abderhalden to determine whether amino acids are produced but disappear because they are absorbed. London mixed amino acids with meat that had been extracted with water to remove any trace of amino acids, and he gave the gastric effluent to Abderhalden for analysis. Abderhalden, using methods already described, did the appropriate control... 

There occurred a ftmdamental change in the type of inventors with which Hoechst cooperated. Most important now were university researchers with rank and title such as Emil Abderhalden and Paul Ehrlich. This change in strategy naturally brought about a reduction in the number of drug inventions offered to the firm. The weak development of Hoechst s own pharmaceutical research structure prevented it from keeping pace quantitatively. 

---